QR-koodi

Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.

OBJECTIVE: To examine the proposal that pretreatment low dose desensitisation may reduce the incidence of toxicity of sulphasalazine in the treatment of rheumatoid arthritis (RA). METHODS: A double blind, placebo controlled trial was performed with 422 patients satisfying the American College of Rhe...

Täydet tiedot

Tallennettuna:
Julkaisussa:Ann Rheum Dis
Päätekijät: McInnes, I B, Porter, D, Murphy, E A, Thomson, E A, Madhok, R, Hunter, J A, Pullar, T, Capell, H A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 1996
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010172/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8660109/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.5.328
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia